AU1371895A - Benzo-fused lactams promote release of growth hormone - Google Patents
Benzo-fused lactams promote release of growth hormoneInfo
- Publication number
- AU1371895A AU1371895A AU13718/95A AU1371895A AU1371895A AU 1371895 A AU1371895 A AU 1371895A AU 13718/95 A AU13718/95 A AU 13718/95A AU 1371895 A AU1371895 A AU 1371895A AU 1371895 A AU1371895 A AU 1371895A
- Authority
- AU
- Australia
- Prior art keywords
- benzo
- growth hormone
- promote release
- fused lactams
- lactams promote
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
- 150000003951 lactams Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14948293A | 1993-12-13 | 1993-12-13 | |
US149482 | 1993-12-13 | ||
PCT/US1994/014374 WO1995016675A1 (en) | 1993-12-13 | 1994-12-09 | Benzo-fused lactams promote release of growth hormone |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1371895A true AU1371895A (en) | 1995-07-03 |
Family
ID=22530482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU13718/95A Abandoned AU1371895A (en) | 1993-12-13 | 1994-12-09 | Benzo-fused lactams promote release of growth hormone |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1371895A (en) |
WO (1) | WO1995016675A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6242199B1 (en) | 1995-12-13 | 2001-06-05 | Merck & Co., Inc. | Assays for growth hormone secretagogue receptors |
US6531314B1 (en) | 1996-12-10 | 2003-03-11 | Merck & Co., Inc. | Growth hormone secretagogue receptor family |
CN1130351C (en) * | 1996-12-10 | 2003-12-10 | 泽里新药工业株式会社 | 1,5-benzodiazepine derivatives |
US6682908B1 (en) | 1998-07-10 | 2004-01-27 | Merck & Co., Inc. | Mouse growth hormone secretagogue receptor |
WO2000002919A1 (en) | 1998-07-13 | 2000-01-20 | Merck & Co., Inc. | Growth hormone secretagogue related receptors and nucleic acids |
WO2000009538A2 (en) | 1998-08-10 | 2000-02-24 | Merck & Co., Inc. | Canine growth hormone secretagogue receptor |
US6380184B1 (en) | 1998-10-28 | 2002-04-30 | Bristol-Myers Squibb Co. | Benzoazepines and analogs thereof useful as growth hormone secretagogues |
WO2000048623A1 (en) | 1999-02-18 | 2000-08-24 | Kaken Pharmaceutical Co., Ltd. | Novel amide derivatives as growth hormone secretagogues |
US6518292B1 (en) | 1999-03-12 | 2003-02-11 | Bristol-Myers Squibb Co. | Heterocyclic aromatic compounds usefuls as growth hormone secretagogues |
US6525203B1 (en) | 1999-03-12 | 2003-02-25 | Bristol-Myers Squibb Company | Heterocyclic aromatic compounds useful as growth hormone secretagogues |
DE60115227T2 (en) | 2000-05-11 | 2006-08-24 | Bristol-Myers Squibb Co. | TETRAHYDROISOCHINOLINE ANALOGUE AS GROWTH HORMONE SECRETAGOGA |
US6649606B1 (en) | 2001-11-09 | 2003-11-18 | Bristol-Myers Squibb Co. | Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity |
UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
EP2155769B1 (en) | 2007-05-04 | 2012-06-27 | Katholieke Universiteit Leuven KU Leuven Research & Development | Tissue degeneration protection |
WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
SG11201609050UA (en) | 2014-05-30 | 2016-12-29 | Pfizer | Carbonitrile derivatives as selective androgen receptor modulators |
WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5374721A (en) * | 1992-10-14 | 1994-12-20 | Merck & Co., Inc. | Benzo-fused lactams promote release of growth hormone |
-
1994
- 1994-12-09 AU AU13718/95A patent/AU1371895A/en not_active Abandoned
- 1994-12-09 WO PCT/US1994/014374 patent/WO1995016675A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1995016675A1 (en) | 1995-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6122194A (en) | Benzo-fused lactams promote release of growth hormone | |
AU7961694A (en) | Benzo-fused lactams promote release of growth hormone | |
AU7401594A (en) | Benzo-fused lactams promote release of growth hormone | |
ZA945462B (en) | Benzo-fused lactams promote release of growth hormone | |
ZA937082B (en) | Benzo-fused lactams promote release of growth hormone | |
ZA937594B (en) | Benzo-fused lactams promote release of growth hormone | |
ZA937222B (en) | Benzo-fused lactams promote release of growth hormone | |
AU1337495A (en) | Heterocyclic-fused lactams promote release of growth hormone | |
AU3964795A (en) | 4-heterocyclic piperidines promote release of growth hormone | |
AU1371895A (en) | Benzo-fused lactams promote release of growth hormone | |
AU5549896A (en) | 3-substituted piperidines promote release of growth hormone | |
AU2334097A (en) | 4-spiroindoline piperidines promote release of growth hormone | |
EP0669830A4 (en) | Substituted dipeptide analogs promote release of growth hormone. | |
AU1868595A (en) | Human growth hormone | |
AU6772996A (en) | 2-acylaminopropanamides as growth hormone secretagogues | |
HUP9900870A3 (en) | Composition for sustained release of human growth hormone | |
EP0726901A4 (en) | Benzo-fused macrocycles promote release of growth hormone | |
AU6724496A (en) | 2-acylaminopropanamines as growth hormone secretagogues | |
GB9323124D0 (en) | Novel benzo-fused lactams inhibit the release of growth hormone | |
GB9604438D0 (en) | Bridged piperidines promoter release of growth hormone | |
GB9612276D0 (en) | 4-Spiroindoline piperidines promote release of growth hormone | |
AU7169696A (en) | 3-spirolactam, 3-spiroamino, 3-spirolactone and 3-spirobenzopyran piperidines and pyrrolidines promote release of growth hormone | |
AU4534596A (en) | Compounds with growth hormone releasing properties | |
GB9602414D0 (en) | Camphor compounds promote release of growth hormone | |
AU4534696A (en) | Compounds with growth hormone releasing properties |